专题：Cancer-related cognitive impairment studies

This cluster of papers explores the mechanisms and impact of chemotherapy-induced cognitive impairment in cancer patients, particularly focusing on breast cancer survivors. It covers topics such as the neurobiological basis of cognitive dysfunction, the role of inflammatory cytokines, longitudinal assessment of cognitive changes, and the effects of adjuvant treatments on cognition.
最新文献
Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease

article Full Text OpenAlex

Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks

article Full Text OpenAlex

A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA

article Full Text OpenAlex

Selective oestrogen receptor modulators and Alzheimer´s disease: a real-world pharmacovigilance study

article Full Text OpenAlex

Abstract GS3-04: Effects of Acupuncture vs Sham Acupuncture and Usual Care on Cancer-Related Cognitive Difficulties Among Breast Cancer Survivors: The ENHANCE Randomized Clinical Trial

article Full Text OpenAlex

Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy

article Full Text OpenAlex

PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape

article Full Text OpenAlex

Study protocol of memantine to preserve memory and neurocognition following craniospinal irradiation: a phase 3 randomized controlled trial (MEMENTO)

article Full Text OpenAlex

Nursing Interventions for Symptom Management in Breast Cancer: A Systematic Review

article Full Text OpenAlex

Emotional and cognitive effects of menopause and hormone replacement therapy

article Full Text OpenAlex

近5年高被引文献
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

article Full Text OpenAlex 1776 FWCI704.7517

Alzheimer's disease drug development pipeline: 2022

review Full Text OpenAlex 656 FWCI97.5691

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

article Full Text OpenAlex 640 FWCI253.7106

Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation

article Full Text OpenAlex 487 FWCI39.3686

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

article Full Text OpenAlex 406 FWCI44.2345

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

article Full Text OpenAlex 341 FWCI33.3833

What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis

review Full Text OpenAlex 277 FWCI27.4183

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers

article Full Text OpenAlex 267 FWCI60.3957

Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship

review Full Text OpenAlex 243 FWCI63.735

Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease

article Full Text OpenAlex 234 FWCI27.2734